Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SBFMW

Sunshine Biopharma (SBFMW)

Sunshine Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SBFMW
DateTimeSourceHeadlineSymbolCompany
06/11/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
06/07/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
05/22/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
05/20/20243:34PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMWSunshine Biopharma Inc
05/15/202410:40AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SBFMWSunshine Biopharma Inc
05/08/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
05/06/202412:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMWSunshine Biopharma Inc
12/04/20238:30AMGlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMWSunshine Biopharma Inc
08/11/20238:30AMGlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMWSunshine Biopharma Inc
05/16/20239:58AMGlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
05/12/20238:00AMGlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
05/11/20239:00AMGlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMWSunshine Biopharma Inc
04/05/20238:00AMGlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMWSunshine Biopharma Inc
02/28/20237:30AMGlobeNewswire Inc.Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentNASDAQ:SBFMWSunshine Biopharma Inc
02/10/20237:35AMGlobeNewswire Inc.Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundNASDAQ:SBFMWSunshine Biopharma Inc
01/19/20237:30AMGlobeNewswire Inc.Sunshine Biopharma Announces Share Repurchase ProgramNASDAQ:SBFMWSunshine Biopharma Inc
12/20/20228:00AMGlobeNewswire Inc.Sunshine Biopharma’s Annual Letter to ShareholdersNASDAQ:SBFMWSunshine Biopharma Inc
11/16/20228:00AMGlobeNewswire Inc.Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA ProjectNASDAQ:SBFMWSunshine Biopharma Inc
10/20/20228:00AMGlobeNewswire Inc.Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueNASDAQ:SBFMWSunshine Biopharma Inc
08/04/20228:00AMGlobeNewswire Inc.Sunshine Biopharma Files Its Second Quarter Report With the SECNASDAQ:SBFMWSunshine Biopharma Inc
07/28/20228:10AMGlobeNewswire Inc.Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
04/28/20224:50PMGlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
04/26/202212:41AMGlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
04/25/20228:00AMGlobeNewswire Inc.Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
04/05/20228:00AMGlobeNewswire Inc.Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer CellsNASDAQ:SBFMWSunshine Biopharma Inc
03/14/20226:12PMGlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
03/10/20229:17AMGlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMWSunshine Biopharma Inc
02/25/202210:20AMInvestorsHub NewsWireSUNSHINE BIOPHARMA EXPANDS ANTI-CORONAVIRUS DRUG DEVELOPMENT PROGRAM BY SIGNING A COLLABORATION AGREEMENT WITH THE UNIVERSITY OF ARIZONANASDAQ:SBFMWSunshine Biopharma Inc
02/25/20228:00AMGlobeNewswire Inc.Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of ArizonaNASDAQ:SBFMWSunshine Biopharma Inc
02/17/202210:07AMGlobeNewswire Inc.Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital MarketNASDAQ:SBFMWSunshine Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SBFMW